Strides Pharma Global (SPG), a step-down wholly-owned subsidiary of Strides Pharma Science in Singapore, proposes to create a platform that shall foster introductions, collaborations, procurement and business engagement between pharmaceutical manufacturers and suppliers of India, China, and other Southeast-Asian countries. In this regard, it is proposed to acquire 100% stake in Amexel, Singapore, which will be utilized as the entity for the above business platform.

SPG has entered into a Share Purchase Agreement to acquire 100% stake in Amexel for a nominal consideration of USD 10.

Amexel, as WOS of SPG, shall focus on: „h

- in-licensing, technology transfers, and the procurement of technical and manufacturing expertise for the production of pharmaceutical products at Strides¡¦ manufacturing facilities (or those of its affiliates) as well as other manufacturers in India. „h

- identifying qualified and approved suppliers, sourcing partners, and providers of APIs, Raw Materials and Packaging materials. „h

- building partnerships with distributors, commercial partners, and customers to support the supply, distribution, and commercialization of products across various territories.

Amexel aims to generate revenue through facilitation services and a profit-sharing model linked to the commercialization of products.